Literature DB >> 16264363

Comparison of different methods of DatSCAN quantification.

Rosemary J Morton1, Matthew J Guy, Ralf Clauss, Paul J Hinton, Craig A Marshall, Elizabeth A Clarke.   

Abstract

BACKGROUND: The quantification of DaTSCAN images can be used as an adjunct to visual assessment to differentiate between Parkinson's syndrome and essential tremor. Many programs have been written to assess the relative uptake in the striatum. AIM: To compare two of the commercially available programs: QuantiSPECT, which analyses isolated data in two dimensions, and BRASS, which performs three-dimensional processing referencing a normal image template.
METHOD: Twenty-two patients (11 with Parkinson's syndrome and 11 with essential tremor) were visually assessed by two nuclear medicine consultants. The patient data were then processed using two commercial programs to determine the relative uptake in the striatum. A comparison of the results from the programs was performed, together with a comparison with the visual assessment. The inter-operator and intra-operator variabilities were also ascertained.
RESULTS: All programs and processing methods could distinguish between Parkinson's syndrome and essential tremor. There was also a good correlation between the results from the three- and two-dimensional methods. The intra-operator and inter-operator variabilities were dependent on the amount of operator intervention.
CONCLUSION: Both programs allowed statistical differentiation between Parkinson's syndrome and essential tremor. Strict operator protocols are needed with QuantiSPECT to reduce inter- and intra-operator variation. The three-dimensional method (BRASS) gave greater concordance than the two-dimensional method (QuantiSPECT) with the visual assessment, but at a cost of increased operator time.

Entities:  

Mesh:

Year:  2005        PMID: 16264363     DOI: 10.1097/00006231-200512000-00015

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  15 in total

Review 1.  SPECT imaging evaluation in movement disorders: far beyond visual assessment.

Authors:  Kosmas Badiavas; Elisavet Molyvda; Ioannis Iakovou; Magdalini Tsolaki; Kyriakos Psarrakos; Nikolaos Karatzas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-02       Impact factor: 9.236

2.  The role of the deep convolutional neural network as an aid to interpreting brain [18F]DOPA PET/CT in the diagnosis of Parkinson's disease.

Authors:  Arnoldo Piccardo; Roberto Cappuccio; Gianluca Bottoni; Diego Cecchin; Luca Mazzella; Alessio Cirone; Sergio Righi; Martina Ugolini; Pietro Bianchi; Pietro Bertolaccini; Elena Lorenzini; Michela Massollo; Antonio Castaldi; Francesco Fiz; Laura Strada; Angelina Cistaro; Massimo Del Sette
Journal:  Eur Radiol       Date:  2021-03-08       Impact factor: 5.315

3.  Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson's disease based on [123I]FP-CIT SPECT images.

Authors:  Francisco P M Oliveira; Diogo Borges Faria; Durval C Costa; Miguel Castelo-Branco; João Manuel R S Tavares
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-23       Impact factor: 9.236

4.  Objective evaluation of reconstruction methods for quantitative SPECT imaging in the absence of ground truth.

Authors:  Abhinav K Jha; Na Song; Brian Caffo; Eric C Frey
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-04-13

5.  Estimating ROI activity concentration with photon-processing and photon-counting SPECT imaging systems.

Authors:  Abhinav K Jha; Eric C Frey
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2015-04-13

6.  Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease.

Authors:  Sule Tinaz; Christopher Chow; Phillip H Kuo; Elizabeth A Krupinski; Hal Blumenfeld; Elan D Louis; George Zubal
Journal:  Clin Nucl Med       Date:  2018-01       Impact factor: 7.794

7.  Establishing On-Site Reference Values for (123)I-FP-CIT SPECT (DaTSCAN®) Using a Cohort of Individuals with Non-Degenerative Conditions.

Authors:  Nicolas Nicastro; Valentina Garibotto; Antoine Poncet; Simon Badoud; Pierre R Burkhard
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

8.  Parkinson subtypes progress differently in clinical course and imaging pattern.

Authors:  Carsten Eggers; David J Pedrosa; Deniz Kahraman; Franziska Maier; Catharine J Lewis; Gereon R Fink; Matthias Schmidt; Lars Timmermann
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

9.  The feasibility of using CT-guided ROI for semiquantifying striatal dopamine transporter availability in a hybrid SPECT/CT system.

Authors:  Chien-Chin Hsu; Yen-Hsiang Chang; Wei-Che Lin; Shu-Wen Tang; Pei-Wen Wang; Yung-Cheng Huang; Nan-Tsing Chiu
Journal:  ScientificWorldJournal       Date:  2014-11-02

10.  Dopamine transporter imaging in psychogenic parkinsonism and neurodegenerative parkinsonism with psychogenic overlay: a report of three cases.

Authors:  Chizoba C Umeh; Zsolt Szabo; Gregory M Pontone; Zoltan Mari
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.